FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380291503> ?p ?o ?g. }

• W4380291503 abstract "Neovascular age-related macular degeneration (nAMD) is a common cause for visual impairment in the ageing population. An increasing number of nAMD patients causes significant health burden, although intravitreal anti-VEGF agents have revolutionized nAMD treatment during the past 15 years. We aimed to define incidence and prevalence of nAMD in different age-categories in the anti-VEGF era and to estimate the number of the individuals over 75 years of age in 2050.We conducted an epidemiological study of the nAMD cohort (n = 2121) in a Finnish population of 410,000 inhabitants. Demographic and clinical data were gathered from Oulu University Hospital's database during 2006-2020. The incidence and prevalence rates were calculated using population data from national registers. The three-year moving average of incidence of nAMD per 100,000 person years was estimated. Prevalence figures were calculated per 100,000 age-specific inhabitants.The average age at the diagnosis of nAMD was 788 years, and 62% of the patients were women. The incidence of nAMD was 71 (95% CI 55-90) and 102 (95% CI 88-118) per 100,000 person years in 2006 and 2020, respectively. During 2006-2020, 1.2- and 2.4-fold increases in nAMD incidence were noted in 75-84 and in 85-96 age groups, respectively. In the oldest 75-84 and 85-96 age categories the nAMD prevalence was 2865/100,000 (3%, 95% CI 2665-3079) and 2620/100,000 (3%, 95% CI 2323-2956), respectively. The proportion of the inhabitants >75 years old is estimated to increase from 10% in 2020 to 17% by 2050.Our results indicate constant 1.2- and 2.4-fold increases in nAMD incidence during the past 15 years in age groups of 75-84 and 85-96 years, respectively, and 3% prevalence of nAMD in 2020. An almost two-fold increase in the ageing population by the year 2050 may also predict the trends in nAMD.KEY MESSAGESThe results of the current population-based study indicate 1.2- and 2.4-fold increases in the incidence of neovascular AMD (nAMD) during the last 15 years in the Finnish population aged 75-84 and 85-96 years and 3% prevalence of nAMD in 2020.An almost two-fold increase in the number of individuals over 75 years of age by the year 2050 is estimated, which may also predict the trends in nAMD.Intravitreal anti-vascular endothelial growth factor (anti-VEGF)- agents have revolutionized the treatment and prognosis of nAMD. Timely recognition and referral of nAMD patients to ophthalmologist can ensure vision-related functionality especially among the ageing population." @default.
• W4380291503 created "2023-06-13" @default.
• W4380291503 creator A5037278855 @default.
• W4380291503 creator A5048642932 @default.
• W4380291503 creator A5052848506 @default.
• W4380291503 creator A5092141850 @default.
• W4380291503 date "2023-06-12" @default.
• W4380291503 modified "2023-09-26" @default.
• W4380291503 title "Incidence and prevalence of neovascular age-related macular degeneration: 15-year epidemiological study in a population-based cohort in Finland" @default.
• W4380291503 cites W1987770475 @default.
• W4380291503 cites W2011538376 @default.
• W4380291503 cites W2053388053 @default.
• W4380291503 cites W2089506571 @default.
• W4380291503 cites W2124415048 @default.
• W4380291503 cites W2133904455 @default.
• W4380291503 cites W2160226180 @default.
• W4380291503 cites W2233221674 @default.
• W4380291503 cites W2727790968 @default.
• W4380291503 cites W2734721636 @default.
• W4380291503 cites W2738996050 @default.
• W4380291503 cites W2768026721 @default.
• W4380291503 cites W2806496552 @default.
• W4380291503 cites W2959393635 @default.
• W4380291503 cites W2985994884 @default.
• W4380291503 cites W3110220146 @default.
• W4380291503 cites W3123851607 @default.
• W4380291503 cites W3128308654 @default.
• W4380291503 cites W3134602936 @default.
• W4380291503 cites W3135827368 @default.
• W4380291503 cites W3152706196 @default.
• W4380291503 cites W3165134660 @default.
• W4380291503 cites W4211020962 @default.
• W4380291503 cites W4247214019 @default.
• W4380291503 cites W4366189161 @default.
• W4380291503 doi "https://doi.org/10.1080/07853890.2023.2222545" @default.
• W4380291503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37306515" @default.
• W4380291503 hasPublicationYear "2023" @default.
• W4380291503 type Work @default.
• W4380291503 citedByCount "0" @default.
• W4380291503 crossrefType "journal-article" @default.
• W4380291503 hasAuthorship W4380291503A5037278855 @default.
• W4380291503 hasAuthorship W4380291503A5048642932 @default.
• W4380291503 hasAuthorship W4380291503A5052848506 @default.
• W4380291503 hasAuthorship W4380291503A5092141850 @default.
• W4380291503 hasBestOaLocation W43802915031 @default.
• W4380291503 hasConcept C107130276 @default.
• W4380291503 hasConcept C118487528 @default.
• W4380291503 hasConcept C120665830 @default.
• W4380291503 hasConcept C121332964 @default.
• W4380291503 hasConcept C126322002 @default.
• W4380291503 hasConcept C144024400 @default.
• W4380291503 hasConcept C149923435 @default.
• W4380291503 hasConcept C187212893 @default.
• W4380291503 hasConcept C201903717 @default.
• W4380291503 hasConcept C2776403814 @default.
• W4380291503 hasConcept C2908647359 @default.
• W4380291503 hasConcept C61511704 @default.
• W4380291503 hasConcept C71924100 @default.
• W4380291503 hasConcept C72563966 @default.
• W4380291503 hasConcept C99454951 @default.
• W4380291503 hasConceptScore W4380291503C107130276 @default.
• W4380291503 hasConceptScore W4380291503C118487528 @default.
• W4380291503 hasConceptScore W4380291503C120665830 @default.
• W4380291503 hasConceptScore W4380291503C121332964 @default.
• W4380291503 hasConceptScore W4380291503C126322002 @default.
• W4380291503 hasConceptScore W4380291503C144024400 @default.
• W4380291503 hasConceptScore W4380291503C149923435 @default.
• W4380291503 hasConceptScore W4380291503C187212893 @default.
• W4380291503 hasConceptScore W4380291503C201903717 @default.
• W4380291503 hasConceptScore W4380291503C2776403814 @default.
• W4380291503 hasConceptScore W4380291503C2908647359 @default.
• W4380291503 hasConceptScore W4380291503C61511704 @default.
• W4380291503 hasConceptScore W4380291503C71924100 @default.
• W4380291503 hasConceptScore W4380291503C72563966 @default.
• W4380291503 hasConceptScore W4380291503C99454951 @default.
• W4380291503 hasIssue "1" @default.
• W4380291503 hasLocation W43802915031 @default.
• W4380291503 hasLocation W43802915032 @default.
• W4380291503 hasLocation W43802915033 @default.
• W4380291503 hasOpenAccess W4380291503 @default.
• W4380291503 hasPrimaryLocation W43802915031 @default.
• W4380291503 hasRelatedWork W1974042200 @default.
• W4380291503 hasRelatedWork W1992459022 @default.
• W4380291503 hasRelatedWork W2048418690 @default.
• W4380291503 hasRelatedWork W2060022074 @default.
• W4380291503 hasRelatedWork W2146312256 @default.
• W4380291503 hasRelatedWork W2350777139 @default.
• W4380291503 hasRelatedWork W2416848835 @default.
• W4380291503 hasRelatedWork W2559287584 @default.
• W4380291503 hasRelatedWork W2909258897 @default.
• W4380291503 hasRelatedWork W3172893480 @default.
• W4380291503 hasVolume "55" @default.
• W4380291503 isParatext "false" @default.
• W4380291503 isRetracted "false" @default.
• W4380291503 workType "article" @default.